Try our beta test site
23 studies found for:    Open Studies | "Vulvar Neoplasms"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting New Strategy for the Treatment of Vulvar Cancer
Condition: Vulvar Neoplasm
Interventions: Procedure: Surgery, radiotherapy and chemotherapy;   Procedure: Surgery
2 Recruiting Ultrasound Morphometric and Cyto/Histological Combined Pre-operative Assessment of Inguinal Lymph Node Status in Women With Invasive Vulvar Carcinoma
Condition: Vulvar Cancer
Intervention: Procedure: Groin ultrasound +/- fine needle aspiration
3 Recruiting Groin Sentinel Node Biopsy and 18FDG-PET/CT in cN0 Vulvar Cancer Patients Candidate to Standard Lymphadenectomy
Condition: Vulvar Cancer
Interventions: Procedure: 18FDG-PET/TC;   Procedure: Sentinel node biopsy
4 Recruiting Interest of the Confocal Microscope in the Diagnosis of Epidermoid Carcinoma of the Vulva and Their Precursors
Conditions: Vulvar Mucosa Lesions;   Vulvar Intraepithelial Neoplasia
Interventions: Other: photographies;   Procedure: biopsy normal area
5 Not yet recruiting Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.
Conditions: Vulvar Cancer;   Cervical Cancer;   Vulvar Dysplasia;   Cervical Dysplasia;   Anal Cancer;   Anal Dysplasia;   HPV-Related Anal Squamous Cell Carcinoma
Interventions: Procedure: Screening anal Pap smear - No high-resolution anoscopy;   Procedure: Screening anal Pap smear - High-resolution anoscopy
6 Recruiting HPV Infections, Cancer of the Vulva and Therapeutical Success
Conditions: HPV;   Human Papilloma Virus
Intervention: Diagnostic Test: polymerase chain reaction
7 Recruiting Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas
Conditions: Cervical Cancer;   Vulvar Cancer;   Anal Cancer;   Oropharynx Cancer
Intervention: Other: CaptHPV method
8 Recruiting Longitudinal Evaluation of Women Undergoing Pelvic Exenteration for Treatment of Gynecologic Malignancy
Conditions: Cervical Cancer;   Endometrial Cancer;   Vaginal Cancer;   Vulvar Cancer;   Gynecologic Cancer
Intervention: Behavioral: Questionnaires
9 Recruiting Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers
Conditions: Cervical Carcinoma;   Ovarian Carcinoma;   Uterine Corpus Cancer;   Vaginal Carcinoma;   Vulvar Carcinoma
Interventions: Procedure: Supportive Care;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
10 Recruiting Image-Guided Gynecologic Brachytherapy
Conditions: Cervical Cancer;   Uterine Cancer;   Vaginal Cancer;   Vulvar Cancer;   Bladder Cancer
Intervention: Device: Image-Guided Brachytherapy
11 Recruiting HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
Conditions: Human Papillomavirus-Related Carcinoma;   Human Papillomavirus Positive Oropharyngeal Carcinoma;   Human Papillomavirus Positive Cervical Carcinoma;   Human Papillomavirus Positive Anal Carcinoma;   Human Papillomavirus Positive Vulvar Carcinoma;   Human Papillomavirus Positive Penile Carcinoma
Interventions: Biological: HPV Specific T Cells;   Drug: Cytoxan;   Drug: Fludarabine;   Biological: Nivolumab
12 Recruiting Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies
Conditions: Cervical Carcinoma;   Ovarian Carcinoma;   Primary Peritoneal Carcinoma;   Recurrent Cervical Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Uterine Corpus Carcinoma;   Recurrent Vulvar Carcinoma;   Uterine Corpus Cancer;   Vulvar Carcinoma;   Peritoneal Neoplasms
Interventions: Other: Palliative Therapy;   Other: Palliative Therapy + idiographic
13 Not yet recruiting Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer
Conditions: Cervical Cancer;   Ovarian Cancer;   Uterine Cancer;   Vaginal Cancer;   Vulval Cancer;   Psychosexual Dysfunctions
Intervention: Behavioral: SAFFRON stepped care
14 Recruiting MR-HIFU for Recurrent Gynaecological Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Uterine Cancer;   Ovarian Cancer;   Vaginal Cancer;   Vulvar Cancer
Intervention: Device: Magnetic Resonance Image-guided High Intensity Focused Ultrasound (MR-HIFU)
15 Recruiting Chemoradiation-Induced Nausea and Emesis: Quality of Life
Conditions: Gastric Cancer;   Pancreatic Cancer;   Cervical Cancer;   Vulvar Cancer;   Endometrial Cancer;   Anal Cancer
Interventions: Behavioral: Interview;   Other: Questionnaire
16 Recruiting Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
Conditions: Ovarian Sarcoma;   Ovarian Stromal Cancer;   Stage I Uterine Sarcoma;   Stage I Vaginal Cancer;   Stage I Vulvar Cancer;   Stage IA Cervical Cancer;   Stage IA Endometrial Carcinoma;   Stage IA Fallopian Tube Cancer;   Stage IA Ovarian Epithelial Cancer;   Stage IA Ovarian Germ Cell Tumor;   Stage IA Primary Peritoneal Cavity Cancer;   Stage IB Cervical Cancer;   Stage IB Endometrial Carcinoma;   Stage IB Fallopian Tube Cancer;   Stage IB Ovarian Epithelial Cancer;   Stage IB Ovarian Germ Cell Tumor;   Stage IB Primary Peritoneal Cavity Cancer;   Stage IC Fallopian Tube Cancer;   Stage IC Ovarian Epithelial Cancer;   Stage IC Ovarian Germ Cell Tumor;   Stage IC Primary Peritoneal Cavity Cancer;   Stage II Endometrial Carcinoma;   Stage II Gestational Trophoblastic Tumor;   Stage II Uterine Sarcoma;   Stage II Vaginal Cancer;   Stage II Vulvar Cancer;   Stage IIA Cervical Cancer;   Stage IIA Fallopian Tube Cancer;   Stage IIA Ovarian Epithelial Cancer;   Stage IIA Ovarian Germ Cell Tumor;   Stage IIA Primary Peritoneal Cavity Cancer;   Stage IIB Cervical Cancer;   Stage IIB Fallopian Tube Cancer;   Stage IIB Ovarian Epithelial Cancer;   Stage IIB Ovarian Germ Cell Tumor;   Stage IIB Primary Peritoneal Cavity Cancer;   Stage IIC Fallopian Tube Cancer;   Stage IIC Ovarian Epithelial Cancer;   Stage IIC Ovarian Germ Cell Tumor;   Stage IIC Primary Peritoneal Cavity Cancer;   Stage III Gestational Trophoblastic Tumor;   Stage III Uterine Sarcoma;   Stage III Vaginal Cancer;   Stage III Vulvar Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Endometrial Carcinoma;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Ovarian Germ Cell Tumor;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Endometrial Carcinoma;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Ovarian Germ Cell Tumor;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Endometrial Carcinoma;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Ovarian Germ Cell Tumor;   Stage IIIC Primary Peritoneal Cavity Cancer;   Breast Cancer
Intervention: Other: behavioral, psychological or informational intervention
17 Recruiting Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy
Conditions: Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Gynecologic Neoplasms;   Fallopian Tube Neoplasms;   Vulvar Neoplasms;   Vaginal Neoplasms;   Peritoneal Neoplasms
Intervention: Behavioral: Specialized Symptom Management and Supportive Care
18 Recruiting Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer;   Sarcoma;   Uterine Leiomyomata;   Vaginal Cancer;   Vulvar Cancer
Interventions: Other: laboratory biomarker analysis;   Other: screening questionnaire administration;   Procedure: study of high risk factors
19 Not yet recruiting Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery
Conditions: Breast Carcinoma;   Head and Neck Cancer;   Melanoma (Skin);   Squamous Cell Carcinoma, Skin;   Cervix Cancer;   Endometrium Cancer;   Ovary Cancer;   Vulva Cancer;   Anus Cancer;   Rectum Cancer
Interventions: Drug: Indocyanine green;   Drug: Technetium99;   Device: Optonuclear probe
20 Recruiting Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
Condition: Advanced Cancer
Intervention: Biological: pembrolizumab

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.